Northern Trust Corp increased its holdings in Quanex Building Products Co. (NYSE:NX - Free Report) by 10.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 490,246 shares of the construction company's stock after acquiring an additional 45,193 shares during the quarter. Northern Trust Corp owned approximately 1.04% of Quanex Building Products worth $11,884,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Pacer Advisors Inc. acquired a new position in shares of Quanex Building Products in the fourth quarter worth about $25,380,000. Barclays PLC lifted its stake in shares of Quanex Building Products by 391.4% in the third quarter. Barclays PLC now owns 83,794 shares of the construction company's stock worth $2,325,000 after acquiring an additional 66,742 shares in the last quarter. Franklin Resources Inc. lifted its stake in shares of Quanex Building Products by 6.4% in the third quarter. Franklin Resources Inc. now owns 19,203 shares of the construction company's stock worth $562,000 after acquiring an additional 1,150 shares in the last quarter. Hennessy Advisors Inc. lifted its stake in shares of Quanex Building Products by 6.8% in the fourth quarter. Hennessy Advisors Inc. now owns 272,618 shares of the construction company's stock worth $6,608,000 after acquiring an additional 17,400 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Quanex Building Products by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 5,267,847 shares of the construction company's stock worth $127,693,000 after acquiring an additional 51,142 shares in the last quarter. Institutional investors and hedge funds own 97.48% of the company's stock.
Quanex Building Products Stock Down 0.3%
Shares of NYSE:NX traded down $0.05 during trading on Thursday, hitting $17.54. The company's stock had a trading volume of 256,053 shares, compared to its average volume of 495,599. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.23 and a current ratio of 2.24. Quanex Building Products Co. has a fifty-two week low of $15.30 and a fifty-two week high of $34.97. The stock's 50-day moving average price is $17.75 and its two-hundred day moving average price is $22.21. The company has a market capitalization of $828.05 million, a PE ratio of 15.66, a PEG ratio of 0.68 and a beta of 1.01.
Quanex Building Products Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 1.82%. The ex-dividend date was Monday, March 17th. Quanex Building Products's payout ratio is currently 52.46%.
About Quanex Building Products
(
Free Report)
Quanex Building Products Corporation, together with its subsidiaries, provides components for the fenestration industry in the United States, rest of Europe, Canada, Asia, the United Kingdom, and internationally. The company operates through three segments: North American Fenestration, European Fenestration, and North American Cabinet Components.
Featured Articles

Before you consider Quanex Building Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanex Building Products wasn't on the list.
While Quanex Building Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.